EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway

Yida Lu, Huizhen Wang, Sihan Chen, Bo Yang, Yaxian Li, Yongxiang Li

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05780-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Yida Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China. Hauptthemen laut MEDLINE: Cell Proliferation, Oxaliplatin, Salivary Cystatins, Stomach Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Anhui Province, Scientific Research Foundation of Education Department of Anhui Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cystatin SA (CST2) belongs to the superfamily of cysteine protease inhibitors. Emerging research indicates that CST2 is often dysregulated across various cancers. Its role and molecular mechanisms in gastric cancer remain underexplored. This study aims to explore the expression and function of CST2 in gastric cancer.

Methods

CST2 expression was analyzed and validated through Western blot. CST2 overexpression was induced by lentivirus in GC cells, and the correlation between CST2 expression levels and downstream signaling pathways was assessed. In addition, multiple assays, including cell proliferation, colony formation, wound-healing, and transwell migration/invasion, were considered to ascertain the influence of CST2 overexpression on gastric cancer. The cell cycle and apoptosis were detected by flow cytometry.

Results

CST2 expression at the protein level was decreased to be reduced in both gastric cancer tissues and cell lines, and CST2 expression attenuate gastric cancer growth, an effect restricted to gastric cancer cells and absent in gastric epithelial GES-1 cells. Furthermore, CST2 was demonstrated to improve chemosensitivity to Oxaliplatin in gastric cancer cells through the PI3K/AKT signaling pathway.

Conclusion

These findings indicate that CST2 is downregulated at the protein level in gastric cancer tissues and cell lines. Additionally, CST2 was found to attenuate the growth of gastric cancer cells and to enhance sensitivity to Oxaliplatin through the PI3K/AKT signaling pathway, specific to gastric cancer cell lines. CST2 may serve as a tumor suppressor gene increasing sensitivity to Oxaliplatin in gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationOxaliplatinSalivary CystatinsStomach NeoplasmsHumansAntineoplastic AgentsApoptosisCell Line, TumorCell MovementDrug Resistance, NeoplasmPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transduction

Stichwörter der Autor:innen

CST2Gastric cancerOxaliplatinPI3K/AKT

Substanzen

Antineoplastic AgentsOxaliplatinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSalivary CystatinsCST2 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China.
  • Taikang Ningbo Hospital, Ningbo, Zhejiang, 315000, People's Republic of China.
  • Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, People's Republic of China. liyongxiangamu@163.com.

Förderung

  • Natural Science Foundation of Anhui Province
  • Scientific Research Foundation of Education Department of Anhui Province
  • National Natural Science Foundation of China

Zitieren

APA

Lu, Y., Wang, H., Chen, S., Yang, B., Li, Y., & Li, Y. (2024). Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05780-9

Vancouver

Lu Y, Wang H, Chen S, Yang B, Li Y, Li Y. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05780-9

BibTeX
@article{Lu2024,
  author = {Lu, Yida and Wang, Huizhen and Chen, Sihan and Yang, Bo and Li, Yaxian and Li, Yongxiang},
  title = {Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05780-9}
}
Kostenlos starten →